A detailed history of Ofi Invest Asset Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ofi Invest Asset Management holds 642 shares of BMY stock, worth $37,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
642
Previous 581 10.5%
Holding current value
$37,030
Previous $29.2 Million 14.73%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $2,455 - $3,232
61 Added 10.5%
642 $24.9 Million
Q1 2024

Apr 29, 2024

BUY
$47.98 - $54.4 $6,381 - $7,235
133 Added 29.69%
581 $29.2 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $775 - $925
-16 Reduced 3.45%
448 $20.8 Million
Q3 2023

Nov 02, 2023

BUY
$57.89 - $64.73 $26,860 - $30,034
464 New
464 $25.4 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $21.6 Million - $24.5 Million
329,222 New
329,222 $22.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ofi Invest Asset Management Portfolio

Follow Ofi Invest Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ofi Invest Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ofi Invest Asset Management with notifications on news.